We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Routine Blood Tests Could Help Predict Fitness Changes

By LabMedica International staff writers
Posted on 29 May 2017
In an initial study of marathoners (runners-bikers) aged >60 years, researchers have found that results from a combination of routine blood analytes predicted improvement or decrease in their fitness.

Beneficial impact of endurance sports on physical and mental performance can be seen in blood test results. More...
In collaboration with the Health and Prevention Center of the Healthcare Institution for City of Vienna employees, a group of researchers from the biobank at Medical University (MedUni) of Vienna has shown, in a study conducted with older marathoners, that specific blood parameters could be used in the opposite way to predict future changes in fitness. This could be used for personalized sports medicine to optimize endurance-training programs for individuals.

Within the Austrian research infrastructure BBMRI.at, MedUni Vienna biobank works closely with the biobanks and medical archives of the other Austrian universities. The consortium has set itself the joint goal of improving the quality of biomaterial used in biomedical studies and hence increasing the reliability of research results nationwide.

In the APSOEM Marathon Study, which has been running since 2009, MedUni Vienna's biobank has already demonstrated that the cognitive ability and mental state of older marathon runners aged >60 are significantly better than those of comparable age groups who do not engage in any endurance sport. Data gathered in this study were used in the new study.

The follow-up study was conducted by a research group headed by Dr. Helmuth Haslacher from MedUni Vienna, in collaboration with Robert Winker's team from the Health and Prevention Center of the Healthcare Institution for City of Vienna employees. They took blood samples from 47 marathoners before an ergometer test, and carried out lab tests to determine levels of analytes, including inflammatory markers, and muscle and liver parameters. Ergometer tests were repeated after an interval of 3 years: approximately 2/3 of the athletes showed a decline in fitness since the initial test. The researchers found that it was possible to use the earlier blood results as a basis for predicting who had lost fitness by the time of the follow-up examination, whose fitness level had remained the same, and whose had even improved.

The next step will be to investigate larger groups and other types of sport. A possible future application would be to develop an app for checking fitness.

They study, by Haslacher H et al, was published May 5, 2017, in the journal PLOS One.


New
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
All-in-One Molecular System
AIO M160
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.